Federated Hermes’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Federated Hermes’s Portfolio SGNT Stock Details SGNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-163,500	Closed	-$4.15M	–	1822
2013 Q4	$4.15M	Sell	163,500 -166,700	-50%	-$3.76M	0.01%	675
2013 Q3	$6.74M	Sell	330,200 -356,900	-52%	-$7.95M	0.03%	489
2013 Q2	$14.4M	Buy	+687,100	New	+$12.3M	0.06%	264

Other funds holding SGNT

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

NIMC

NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

PCM

Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return

Federated Hermes's SGNT Position: Q1 2014 in Review

Federated Hermes sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q1 2014, closing a stake of 163,500 shares — an estimated $4.15M sold.

Federated Hermes first reported a position in SGNT in Q2 2013 and held it in 3 quarters. The position peaked at $14.4M in Q2 2013. 94 funds tracked by Wall St. Rank hold SGNT as of Q1 2014.

Federated Hermes reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q1 2014 after selling out during the quarter.
Federated Hermes sold 163,500 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q1 2014, an estimated $4.15M.
Federated Hermes first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 3 quarters.
Federated Hermes's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $14.4M in Q2 2013.
94 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q1 2014.

Based on Federated Hermes's 13F filing for Q1 2014, filed 6 May 2014.